🤗🤗🤗 I'm glad and happy to announce that our grant proposal "Hypoxia-inducible factor in hereditary hemorrhagic telangiectasia" has been approved for funding by the @dfg_public 🥳🥳🥳 #HHT#HIF@freyadroege@unidue@MedEssen
Grateful for receiving the Best Poster Award. It was amazing to attend the 13th Annual Meeting of the Young Physiologists in Mannheim #PosterAward#physiologie#YoungPhysiologist 🥳☺️🤗
🥳Happy to share our latest publication on #HIF and #HHT
Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia https://t.co/eiUtMh90xG #mdpilife via @Life_MDPI@freyadroege
#GivingTuesday is just around the corner! Stay tuned as we’ll be highlighting a few of our standout young scholars who help keep us #OnTheCuttingEdge.
Please consider #CureHHT this Giving Tuesday: https://t.co/Y6gDI5cibP
The world's leading experts in #HHT arriving -- all in one room, working together. All for patients.
Thank you for creating this, @WillAutomate#HHTSciCon2022
Great poster presentation from my master student and future doctoral student at #Europhysiology2022 about metabolism and #HIF in immune cells of #hht patients 👏🏼